{"entity":{"id":"thomas-george","kind":"person","name":"Thomas J. George","aka":[],"tldr":"Oncologist (FACP, FASCO) who is Interim Director of the UF Health Cancer Institute in Gainesville, Florida's only NCI-designated cancer centre based at a public university.","summary":"Thomas J. George, MD, FACP, FASCO, is Interim Director of the UF Health Cancer Institute, the University of Florida's cancer centre in Gainesville, and writes the director's welcome on its website. The institute became the 72nd NCI-designated cancer centre in June 2023 and is the only one based at a public university in Florida. It serves a 26-county area of north central Florida, has more than 350 researcher, clinician and educator members across the University of Florida and UF Health, and its clinical services include proton therapy, stem cell transplantation and immunotherapy. The leadership page did not give an appointment date.","asOf":"2026-09-10","links":[{"label":"Source: UF Health Cancer Institute leadership page","url":"https://cancer.ufl.edu/about/leadership/"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":["proton-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":["uf-health-cancer-center"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Interim Director, UF Health Cancer Institute (University of Florida Health Cancer Center)","institutionId":"uf-health-cancer-center","specialisms":["Oncology","Academic cancer centre leadership"],"profiles":[{"label":"UF Health Cancer Institute leadership page","url":"https://cancer.ufl.edu/about/leadership/"},{"label":"Interim director's welcome","url":"https://cancer.ufl.edu/about/welcome-overview/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=George+TJ%5BAuthor%5D+AND+Florida"}],"papers":[{"title":"Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer","journal":"JAMA Oncology","year":2021,"doi":"10.1001/jamaoncol.2021.1683"},{"title":"Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma","journal":"Journal of Clinical Oncology","year":2023,"doi":"10.1200/jco.22.02525"},{"title":"Neoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical Trials","journal":"Current Colorectal Cancer Reports","year":2015,"doi":"10.1007/s11888-015-0285-2"}]},"route":"/people/thomas-george/","neighbours":{"technology":[{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"}],"institution":[{"id":"uf-health-cancer-center","kind":"institution","name":"University of Florida Health Cancer Center","route":"/institutions/uf-health-cancer-center/"}]}}